1	Angiotensin	Angiotensin	B-NP	NN	B-protein	3	SUB	-1
2	II	II	I-NP	CD	I-protein	1	NMOD	-1
3	induces	induce	B-VP	VBZ	O	0	ROOT	16	induces
4	soluble	soluble	B-NP	JJ	B-protein	7	NMOD	-1
5	fms-Like	fms-Like	I-NP	NN	I-protein	7	NMOD	-1
6	tyrosine	tyrosine	I-NP	NN	I-protein	7	NMOD	-1
7	kinase-1	kinase-1	I-NP	NN	I-protein	8	NMOD	-1
8	release	release	I-NP	NN	O	3	OBJ	14	release
9	via	via	B-PP	IN	O	3	VMOD	0
10	calcineurin	calcineurin	B-NP	NN	B-protein	12	NMOD	-1
11	signaling	signaling	I-NP	NN	O	12	NMOD	0
12	pathway	pathway	I-NP	NN	O	9	PMOD	0
13	in	in	B-PP	IN	O	12	NMOD	-1
14	pregnancy	pregnancy	B-NP	NN	O	13	PMOD	-1
15	.	.	O	.	O	3	P	-1

1	Maternal	Maternal	B-NP	JJ	O	3	NMOD	-1
2	endothelial	endothelial	I-NP	JJ	O	3	NMOD	-1
3	dysfunction	dysfunction	I-NP	NN	O	6	SUB	6	dysfunction
4	in	in	B-PP	IN	O	3	NMOD	-1
5	preeclampsia	preeclampsia	B-NP	NN	O	4	PMOD	-1
6	is	be	B-VP	VBZ	O	0	ROOT	-1
7	associated	associate	I-VP	VBN	O	6	VC	0
8	with	with	B-PP	IN	O	7	VMOD	-1
9	increased	increase	B-NP	VBN	O	13	NMOD	17	increased
10	soluble	soluble	I-NP	JJ	B-protein	13	NMOD	-1
11	fms-like	fms-like	I-NP	JJ	I-protein	13	NMOD	-1
12	tyrosine	tyrosine	I-NP	NN	I-protein	13	NMOD	-1
13	kinase-1	kinase-1	I-NP	NN	I-protein	20	NMOD	-1
14	(	(	O	(	O	16	DEP	-1
15	sFlt-1	sFlt-1	B-NP	NN	O	16	DEP	-1
16	)	)	O	)	O	13	NMOD	-1
17	,	,	O	,	O	20	P	-1
18	a	a	B-NP	DT	O	20	NMOD	-1
19	circulating	circulate	I-NP	VBG	O	20	NMOD	14	circulating
20	antagonist	antagonist	I-NP	NN	O	8	PMOD	-1
21	of	of	B-PP	IN	O	20	NMOD	-1
22	vascular	vascular	B-NP	JJ	B-protein	25	NMOD	-1
23	endothelial	endothelial	I-NP	JJ	I-protein	25	NMOD	-1
24	growth	growth	I-NP	NN	I-protein	25	NMOD	0
25	factor	factor	I-NP	NN	I-protein	29	NMOD	-1
26	and	and	O	CC	O	29	NMOD	-1
27	placental	placental	B-NP	JJ	B-protein	29	NMOD	-1
28	growth	growth	I-NP	NN	I-protein	29	NMOD	0
29	factor	factor	I-NP	NN	I-protein	21	PMOD	-1
30	.	.	O	.	O	6	P	-1

1	Angiotensin	Angiotensin	B-NP	NN	B-protein	7	SUB	-1
2	II	II	I-NP	CD	I-protein	1	NMOD	-1
3	(	(	O	(	O	6	DEP	-1
4	Ang	Ang	B-NP	NN	B-protein	6	DEP	-1
5	II	II	I-NP	CD	I-protein	4	NMOD	-1
6	)	)	O	)	O	1	NMOD	-1
7	is	be	B-VP	VBZ	O	0	ROOT	-1
8	a	a	B-NP	DT	O	10	NMOD	-1
9	potent	potent	I-NP	JJ	O	10	NMOD	-1
10	vasoconstrictor	vasoconstrictor	I-NP	NN	O	7	PRD	-1
11	that	that	B-NP	WDT	O	10	NMOD	-1
12	increases	increase	B-VP	VBZ	O	11	SBAR	17	increases
13	concomitant	concomitant	B-ADJP	JJ	O	12	VMOD	-1
14	with	with	B-PP	IN	O	13	AMOD	-1
15	sFlt-1	sFlt-1	B-NP	NN	O	14	PMOD	-1
16	during	during	B-PP	IN	O	12	VMOD	-1
17	pregnancy	pregnancy	B-NP	NN	O	16	PMOD	-1
18	.	.	O	.	O	7	P	-1

1	Therefore	Therefore	B-ADVP	RB	O	4	VMOD	-1
2	,	,	O	,	O	4	P	-1
3	we	we	B-NP	PRP	O	4	SUB	-1
4	speculated	speculate	B-VP	VBD	O	0	ROOT	-1
5	that	that	B-SBAR	IN	O	4	VMOD	-1
6	Ang	Ang	B-NP	NN	B-protein	8	SUB	-1
7	II	II	I-NP	CD	I-protein	6	NMOD	-1
8	may	may	B-VP	MD	O	5	SBAR	-1
9	promote	promote	I-VP	VB	O	8	VC	17	promote
10	the	the	B-NP	DT	O	11	NMOD	-1
11	expression	expression	I-NP	NN	O	9	OBJ	9	expression
12	of	of	B-PP	IN	O	11	NMOD	-1
13	sFlt-1	sFlt-1	B-NP	NN	B-protein	12	PMOD	-1
14	in	in	B-PP	IN	O	11	NMOD	-1
15	pregnancy	pregnancy	B-NP	NN	O	14	PMOD	-1
16	.	.	O	.	O	4	P	-1

1	Here	Here	B-ADVP	RB	O	3	VMOD	-1
2	we	we	B-NP	PRP	O	3	SUB	-1
3	report	report	B-VP	VBP	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	infusion	infusion	B-NP	NN	O	10	SUB	19	infusion
6	of	of	B-PP	IN	O	5	NMOD	-1
7	Ang	Ang	B-NP	NN	B-protein	6	PMOD	-1
8	II	II	I-NP	CD	I-protein	7	NMOD	-1
9	significantly	significantly	B-VP	RB	O	10	VMOD	-1
10	increases	increase	I-VP	VBZ	O	4	SBAR	17	increases
11	circulating	circulate	I-VP	VBG	O	12	NMOD	14	circulating
12	levels	level	B-NP	NNS	O	10	OBJ	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	sFlt-1	sFlt-1	B-NP	NN	B-protein	13	PMOD	-1
15	in	in	B-PP	IN	O	12	NMOD	-1
16	pregnant	pregnant	B-NP	JJ	O	17	NMOD	-1
17	mice	mouse	I-NP	NNS	O	15	PMOD	-1
18	,	,	O	,	O	10	P	-1
19	thereby	thereby	B-VP	RB	O	20	VMOD	-1
20	demonstrating	demonstrate	I-VP	VBG	O	10	VMOD	-1
21	that	that	B-SBAR	IN	O	20	VMOD	-1
22	Ang	Ang	B-NP	NN	B-protein	24	SUB	-1
23	II	II	I-NP	CD	I-protein	22	NMOD	-1
24	is	be	B-VP	VBZ	O	21	SBAR	-1
25	a	a	B-NP	DT	O	26	NMOD	-1
26	regulator	regulator	I-NP	NN	O	24	PRD	0
27	of	of	B-PP	IN	O	26	NMOD	-1
28	sFlt-1	sFlt-1	B-NP	NN	O	29	NMOD	-1
29	secretion	secretion	I-NP	NN	O	27	PMOD	14	secretion
30	in	in	B-ADVP	FW	O	24	VMOD	-1
31	vivo	vivo	I-ADVP	FW	O	30	AMOD	-1
32	.	.	O	.	O	3	P	-1

1	Furthermore	Furthermore	B-ADVP	RB	O	5	VMOD	-1
2	,	,	O	,	O	5	P	-1
3	Ang	Ang	B-NP	NN	B-protein	5	SUB	-1
4	II	II	I-NP	CD	I-protein	3	NMOD	-1
5	stimulated	stimulate	B-VP	VBD	O	0	ROOT	17	stimulated
6	sFlt-1	sFlt-1	B-NP	NN	O	7	NMOD	-1
7	production	production	I-NP	NN	O	5	OBJ	9	production
8	in	in	B-PP	IN	O	5	VMOD	-1
9	a	a	B-NP	DT	O	13	NMOD	-1
10	dose-	dose-	I-NP	NN	O	12	AMOD	-1
11	and	and	I-NP	CC	O	12	AMOD	-1
12	time-dependent	time-dependent	I-NP	JJ	O	13	NMOD	-1
13	manner	manner	I-NP	NN	O	8	PMOD	-1
14	from	from	B-PP	IN	O	5	VMOD	-1
15	human	human	B-NP	JJ	O	17	NMOD	-1
16	villous	villous	I-NP	JJ	O	17	NMOD	-1
17	explants	explant	I-NP	NNS	O	20	NMOD	-1
18	and	and	O	CC	O	20	NMOD	-1
19	cultured	culture	B-NP	VBN	B-cell_line	20	NMOD	0
20	trophoblasts	trophoblast	I-NP	NNS	I-cell_line	14	PMOD	-1
21	but	but	B-PP	CC	O	14	PMOD	-1
22	not	not	B-PP	RB	O	23	PMOD	-1
23	from	from	I-PP	IN	O	14	PMOD	-1
24	endothelial	endothelial	B-NP	JJ	B-cell_type	25	NMOD	-1
25	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	-1
26	,	,	O	,	O	5	P	-1
27	suggesting	suggest	B-VP	VBG	O	5	VMOD	-1
28	that	that	B-SBAR	IN	O	27	VMOD	-1
29	trophoblasts	trophoblast	B-NP	NNS	O	30	SUB	-1
30	are	be	B-VP	VBP	O	28	SBAR	-1
31	the	the	B-NP	DT	O	33	NMOD	-1
32	primary	primary	I-NP	JJ	O	33	NMOD	-1
33	source	source	I-NP	NN	O	30	PRD	-1
34	of	of	B-PP	IN	O	33	NMOD	-1
35	sFlt-1	sFlt-1	B-NP	NN	O	34	PMOD	-1
36	during	during	B-PP	IN	O	33	NMOD	-1
37	pregnancy	pregnancy	B-NP	NN	O	36	PMOD	-1
38	.	.	O	.	O	5	P	-1

1	As	As	B-SBAR	IN	O	8	VMOD	-1
2	expected	expect	B-VP	VBN	O	1	SBAR	-1
3	,	,	O	,	O	8	P	-1
4	Ang	Ang	B-NP	NNP	O	7	NMOD	-1
5	II-induced	II-induced	I-NP	JJ	O	7	NMOD	17	induced
6	sFlt-1	sFlt-1	I-NP	NN	O	7	NMOD	-1
7	secretion	secretion	I-NP	NN	O	8	SUB	14	secretion
8	resulted	result	B-VP	VBD	O	0	ROOT	0
9	in	in	B-PP	IN	O	8	VMOD	-1
10	the	the	B-NP	DT	O	11	NMOD	-1
11	inhibition	inhibition	I-NP	NN	O	20	NMOD	17	inhibition
12	of	of	B-PP	IN	O	11	NMOD	-1
13	endothelial	endothelial	B-NP	JJ	B-cell_type	15	NMOD	-1
14	cell	cell	I-NP	NN	I-cell_type	15	NMOD	-1
15	migration	migration	I-NP	NN	O	12	PMOD	14	migration
16	and	and	O	CC	O	20	NMOD	-1
17	in	in	B-NP	FW	O	18	AMOD	-1
18	vitro	vitro	I-NP	FW	O	20	NMOD	-1
19	tube	tube	I-NP	NN	O	20	NMOD	-1
20	formation	formation	I-NP	NN	O	9	PMOD	2	formation
21	.	.	O	.	O	8	P	-1

1	In	In	B-ADVP	FW	O	2	AMOD	-1
2	vitro	vitro	I-ADVP	FW	O	6	NMOD	-1
3	and	and	O	CC	O	6	NMOD	-1
4	in	in	B-NP	FW	O	5	AMOD	-1
5	vivo	vivo	I-NP	FW	O	6	NMOD	-1
6	studies	study	I-NP	NNS	O	18	SUB	-1
7	with	with	B-PP	IN	O	6	NMOD	-1
8	losartan	losartan	B-NP	NN	O	12	NMOD	-1
9	,	,	O	,	O	12	P	-1
10	small	small	B-NP	JJ	O	12	NMOD	-1
11	interfering	interfere	I-NP	VBG	O	12	NMOD	-1
12	RNA	RNA	I-NP	NN	O	7	PMOD	-1
13	specific	specific	B-ADJP	JJ	O	12	NMOD	-1
14	for	for	B-PP	IN	O	13	AMOD	-1
15	calcineurin	calcineurin	B-NP	NN	B-protein	17	NMOD	-1
16	and	and	I-NP	CC	O	17	NMOD	-1
17	FK506	FK506	I-NP	NN	O	14	PMOD	-1
18	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	-1
19	that	that	B-SBAR	IN	O	18	VMOD	-1
20	Ang	Ang	B-NP	NNP	O	23	NMOD	-1
21	II-mediated	II-mediated	I-NP	JJ	O	23	NMOD	16	mediated
22	sFlt-1	sFlt-1	I-NP	NN	O	23	NMOD	-1
23	release	release	I-NP	NN	O	24	SUB	14	release
24	was	be	B-VP	VBD	O	19	SBAR	-1
25	via	via	B-PP	IN	O	24	PRD	0
26	Ang	Ang	B-NP	NNP	B-protein	30	NMOD	-1
27	II	II	I-NP	CD	I-protein	30	NMOD	-1
28	type	type	I-NP	NN	I-protein	30	NMOD	-1
29	1	1	I-NP	CD	I-protein	30	NMOD	-1
30	receptor	receptor	I-NP	NN	I-protein	34	NMOD	-1
31	activation	activation	B-NP	NN	O	34	NMOD	17	activation
32	and	and	O	CC	O	34	NMOD	-1
33	calcineurin	calcineurin	B-NP	NN	B-protein	34	NMOD	-1
34	signaling	signaling	I-NP	NN	O	25	PMOD	0
35	,	,	O	,	O	24	P	-1
36	respectively	respectively	B-ADVP	RB	O	24	VMOD	-1
37	.	.	O	.	O	18	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	findings	finding	I-NP	NNS	O	3	SUB	-1
3	reveal	reveal	B-VP	VBP	O	0	ROOT	-1
4	a	a	B-NP	DT	O	8	NMOD	-1
5	previously	previously	I-NP	RB	O	6	AMOD	-1
6	unrecognized	unrecognized	I-NP	JJ	O	8	NMOD	-1
7	regulatory	regulatory	I-NP	JJ	O	8	NMOD	-1
8	role	role	I-NP	NN	O	3	OBJ	0
9	for	for	B-PP	IN	O	8	NMOD	-1
10	Ang	Ang	B-NP	NN	B-protein	9	PMOD	-1
11	II	II	I-NP	CD	I-protein	10	NMOD	-1
12	on	on	B-PP	IN	O	8	NMOD	-1
13	sFlt-1	sFlt-1	B-NP	NN	O	14	NMOD	-1
14	expression	expression	I-NP	NN	O	12	PMOD	9	expression
15	in	in	B-PP	IN	O	14	NMOD	-1
16	murine	murine	B-NP	JJ	O	19	NMOD	-1
17	and	and	I-NP	CC	O	19	NMOD	-1
18	human	human	I-NP	JJ	O	19	NMOD	-1
19	pregnancy	pregnancy	I-NP	NN	O	15	PMOD	-1
20	and	and	O	CC	O	3	VMOD	-1
21	suggest	suggest	B-VP	VBP	O	3	VMOD	-1
22	that	that	B-SBAR	IN	O	21	VMOD	-1
23	elevated	elevate	B-NP	VBN	O	25	NMOD	17	elevated
24	sFlt-1	sFlt-1	I-NP	NN	O	25	NMOD	-1
25	levels	level	I-NP	NNS	O	28	SUB	-1
26	in	in	B-PP	IN	O	25	NMOD	-1
27	preeclampsia	preeclampsia	B-NP	NN	O	26	PMOD	-1
28	may	may	B-VP	MD	O	22	SBAR	-1
29	be	be	I-VP	VB	O	28	VC	-1
30	caused	cause	I-VP	VBN	O	29	VC	17	caused
31	by	by	B-PP	IN	O	30	VMOD	-1
32	a	a	B-NP	DT	O	33	NMOD	-1
33	dysregulation	dysregulation	I-NP	NN	O	31	PMOD	18	dysregulation
34	of	of	B-PP	IN	O	33	NMOD	-1
35	the	the	B-NP	DT	O	38	NMOD	-1
36	local	local	I-NP	JJ	O	38	NMOD	-1
37	renin/angiotensin	renin/angiotensin	I-NP	NN	O	38	NMOD	-1
38	system	system	I-NP	NN	O	34	PMOD	0
39	.	.	O	.	O	3	P	-1

